In an industry where 90 percent of drug candidates fail before reaching the market, a handful of startups are betting ...

In April 2025, the US Food and Drug Administration (FDA) published a roadmap for leveraging new approach methodologies (NAMs), including in silico approaches such as artificial intelligence (AI), to ...

Top regulators like the US FDA and EMA are fast-tracking more Chinese drugs, granting priority review and breakthrough ...

New module addresses multi-billion-dollar data quality challenge in life sciences by automating data cleansing, standardization, and transformation for AI readiness ...

The biotechnology industry is experiencing a tectonic shift, driven by Chinese drugmakers who have come a long way from their ...

US FDA 200+CRLs to help pharma industry engage in a more transparent manner: Experts: Shardul Nautiyal, Mumbai Friday, July 18, 2025, 08:00 Hrs [IST] US FDA 200+Complete Response ...

In an effort to foster progress in cancer research, the National Institute of Standards and Technology (NIST) is releasing detailed and comprehensive data about the entire genetic content of a ...

GeneDx leverages a vast rare disease database and advanced genomic testing, offering superior insights. Read why I am bullish about WGS stock.

In an effort to foster progress in cancer research, the National Institute of Standards and Technology (NIST) is releasing ...

A PDAC cell line was generated from a patient who consented to make the genetic code of her cancer cells publicly available ...

A PDAC cell line was generated from a patient who consented to make the genetic code of her cancer cells publicly available ...